CLB vs CNQ
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CLB exhibits a concerning divergence between its current market price ($17.45) and its deterministic value markers, with a Piotroski F-Score of 4/9 indicating only stable health. The stock is trading at a significant premium to both its Graham Number ($9.04) and Intrinsic Value ($4.41), while experiencing a sharp YoY earnings decline of 31.60%. Despite a strong 1-year price rally, the underlying fundamentals—specifically the negative earnings growth and bearish technical trend—suggest the current valuation is unsustainable.
CNQ demonstrates exceptional fundamental strength, anchored by a Piotroski F-Score of 8/9 and a superior ROE of 25.81% that dwarfs the sector average. While the current price of $44.24 is slightly above the Graham Number ($36.37), it trades at a massive discount to its growth-based intrinsic value of $111.22. Despite a bearish technical trend (0/100), the company's low P/E ratio and sustainable dividend payout provide a significant margin of safety. The explosive YoY earnings growth suggests high operational efficiency and cost management despite stagnant revenue growth.
Compare Another Pair
Related Comparisons
CLB vs CNQ: Head-to-Head Comparison
This page compares Core Laboratories Inc. (CLB) and Canadian Natural Resources Limited (CNQ) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.